Orchid Pharma Shareholding Pattern
- Market cap
- ₹4,933 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹700.31 – ₹1,313.08
As of Jun 2026, promoters held 48.50% of Orchid Pharma, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Orchid Pharma shareholding pattern — frequently asked questions
What is the promoter holding in Orchid Pharma?
Promoters held 48.50% of Orchid Pharma as of Jun 2026.
How much do FIIs hold in Orchid Pharma?
Foreign institutional investors held 18.40% of Orchid Pharma as of Jun 2026.
How much do domestic institutions hold in Orchid Pharma?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Orchid Pharma as of Jun 2026; mutual funds alone held 8.50%.
Who owns Orchid Pharma?
As of Jun 2026, Orchid Pharma's shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
- Par Drugs and Chemicals Limited shareholding pattern
- Onesource Specialty Pharma Limited shareholding pattern
- Pfizer Limited shareholding pattern
- Narayana Hrudayalaya Limited. shareholding pattern
- Procter & Gamble Hygiene and Health Care Limited shareholding pattern
- Neuland Laboratories Limited shareholding pattern
Trade Orchid Pharma With ATS
Track ORCHPHARMA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.